Prior studies by our laboratory during the last grant cycle have demonstrated that the in vitro addition of 1,25(OH)2D3 (10-(8) to 10-(11) M) rapidly (sec to min) stimulated phosphoinositide turnover, activated PKC, increased [Ca2+](i) and decreased [pH](i), via inhibition of the Na+/H+ exchange, in the large intestine of vitamin D-sufficient rats and in CaCo-2 cells. Furthermore, 1,25(OH)2D3 and bethanechol chloride failed to elicit any of these aforementioned colonic biochemical responses in D-deficient rats. In vivo repletion of these D-deficient animals with 1,25(OH)2D3 for 5 to 7 days, however, restored the rapid biochemical effects of in vitro 1,25(OH)2D3 and bethanechol in this organ. Based on these prior findings, the three major specific aims of the present proposal are to: 1) further elucidate the mechanisms involved in the rapid, in vitro actions of 1,25(OH)2D3 on the phosphoinositide signal transduction system in the large intestine of vitamin D-sufficient rats and in CaCo-2 cells; 2) further characterize the physiological consequence of these rapid, in vitro biochemical actions of 1,25(OH)2D3 in the large intestine of vitamin D-sufficient rats and in CaCo-2 cells; and 3) determine the mechanism(s) responsible for the loss of these rapid, in vitro actions of 1,25(OH)2D3 in the large intestine of vitamin D-deficient animals and their correction by in vivo administration of 1,25(OH)2D3. It is strongly anticipated that the successful achievement of these specific aims should increase our knowledge with respect to the mechanisms of action and physiological effects of 1,25(OH)2D3 in these cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK039573-05
Application #
2140966
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1989-07-01
Project End
1997-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Khare, Sharad; Cerda, Sonia; Wali, Ramesh K et al. (2003) Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Res 63:3517-23
Wali, Ramesh K; Stoiber, Debra; Nguyen, Lan et al. (2002) Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiol Biomarkers Prev 11:1316-21
Wali, Ramesh K; Khare, Sharad; Tretiakova, Maria et al. (2002) Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol Biomarkers Prev 11:1653-62
Alrefai, W A; Scaglione-Sewell, B; Tyagi, S et al. (2001) Differential regulation of the expression of Na(+)/H(+) exchanger isoform NHE3 by PKC-alpha in Caco-2 cells. Am J Physiol Cell Physiol 281:C1551-8
Cerda, S R; Bissonnette, M; Scaglione-Sewell, B et al. (2001) PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 120:1700-12
Scaglione-Sewell, B A; Bissonnette, M; Skarosi, S et al. (2000) A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1. Endocrinology 141:3931-9
Chen, A; Davis, B H; Bissonnette, M et al. (1999) 1,25-Dihydroxyvitamin D(3) stimulates activator protein-1-dependent Caco-2 cell differentiation. J Biol Chem 274:35505-13
Wali, R K; Bissonnette, M; Skarosi, S et al. (1998) 1,25-Dihydroxyvitamin D3 targets PKC-betaII but not PKC-alpha to the basolateral plasma membranes of rat colonocytes. Biochem Biophys Res Commun 250:48-52
Scaglione-Sewell, B; Abraham, C; Bissonnette, M et al. (1998) Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res 58:1074-81
Abraham, C; Scaglione-Sewell, B; Skarosi, S F et al. (1998) Protein kinase C alpha modulates growth and differentiation in Caco-2 cells. Gastroenterology 114:503-9

Showing the most recent 10 out of 32 publications